Patients Why Britain's blood tests are only as reliable as the journe... What happens in phlebotomy has a huge impact in pathology, and the different funding streams and management means that interests are no longer aligned
Sales & Marketing Why trust is becoming pharma’s most important visibility met... Any gap between an AI-generated answer and a product’s approved profile carries consequences for prescribing decisions and patient safety.
Market Access Fighting fake GLP-1s to protect patients & preserve trust Counterfeit drug promotion is a patient safety, brand equity, and public trust issue.
Patients Every child deserves safe care from day one Patient safety remains one of the most pressing global health challenges of our time.
Patients Strengthening safety: The critical role of reliable labellin... Learn more about the important role that labelling plays within pharmaceutical labelling and across blood transfusions.
R&D Defining success for early-stage, small biotech trials Small biotech companies encounter significant challenges in designing and implementing clinical development programmes.
News Sobi adds rare lymphoma drug with $580m Innate tie-up Sobi chief executive Guido Oelkers is preparing his exit, but is still cutting deals, licensing a lymphoma drug from Innate for up to $580m.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.